Sustaining and Improving Clinicians' Use of Evidence-Based Psychotherapy (EBP) for PTSD

NCT02449421 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2024-01-17

No results posted yet for this study

Summary

The purpose of the study is to compare the impact of two strategies to sustain and improve the delivery of an evidence-based psychotherapy for PTSD, Cognitive Processing Therapy (CPT) in three different mental health systems. These approaches are based on two different theories of what is necessary to promote successful implementation. We will examine whether these strategies lead to improved patient outcomes, clinician skill, proportion of clients who receive CPT, and other outcomes that are relevant to the implementation of evidence-based psychosocial treatments. By examining these questions in 3 different mental health systems, we will also examine whether the implementation strategies yield different results in different systems.

Conditions

  • Post Traumatic Stress Disorder

Interventions

BEHAVIORAL

Quality Improvement Learning Community

Consultation with CPT experts to effectively use evidence-based psychotherapy.

BEHAVIORAL

Fidelity-oriented Learning Community

The Fidelity-oriented Learning Community arm will receive fidelity consultation (adherence and competence) feedback by a CPT expert via online meetings.

Sponsors & Collaborators

  • Stanford University

    collaborator OTHER
  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV
  • National Institute of Mental Health (NIMH)

    collaborator NIH
  • Palo Alto Veterans Institute for Research

    collaborator OTHER
  • National Center for PTSD

    collaborator FED
  • Toronto Metropolitan University

    lead OTHER

Principal Investigators

  • Candice Monson, PhD · Toronto Metropolitan University

  • Shannon Wiltsey Stirman, PhD · National Center for PTSD

  • Norman Shields, PhD · Royal Canadian Mounted Police

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-06
Primary Completion
2022-12-31
Completion
2024-06-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02449421 on ClinicalTrials.gov